Filter:

Topic(s)

Resource(s)

Filter by

Topic

Resource

Case study

Whether to stop prescribing off-label drugs

A GP was concerned about the risks of stopping a patient's prescription for sodium valproate, and called the MDU for advice.

Read more
Case study

GMC investigation over prescribing concerns

After being notified about some potential prescription anomalies, the GMC wrote to a hospital consultant, who in turn called on the MDU for advice.

Read more
Guide

Self-prescribing

Self-prescribing can lead to serious consequences. Read our guidance on prescribing for yourself or for anyone you have a close personal relationship with.

Read more
FAQ

What should I do if a patient refuses to attend for a medication review?

The patient's choice makes it difficult to monitor their condition and is a particular concern if they are taking high-risk drugs...

Read more
FAQ

Can I prescribe unlicensed/off-label medicines in palliative care?

The GMC's existing prescribing guidance is clear that you may prescribe unlicensed medicines where it is necessary to meet the specific needs of...

Read more
Journal

Alleged failure to review 'out of date' medication

The MDU supported a GP member with an allegation of failing to review a medication's expiry date.

Read more
Journal

Risk management of mesalazine induced renal failure

The MDU has noticed an increase in notification of claims related to renal impairment alleged to be secondary to mesalazine prescribed for inflammatory bowel disease.

Read more
Journal

AI in healthcare

Artificial intelligence has the potential to transform aspects of clinical practice but we must think carefully about its adoption and regulation, says Dr Farzana Rahman.

Read more
Guide

Prescribing cannabis-based products

From 1 November 2018, specialist UK doctors were able to prescribe medicinal cannabis.

Read more